Written answers

Tuesday, 28 July 2020

Department of Health

Medicinal Products

Photo of Jennifer Carroll MacNeillJennifer Carroll MacNeill (Dún Laoghaire, Fine Gael)
Link to this: Individually | In context | Oireachtas source

929. To ask the Minister for Health if a matter raised in correspondence by a person (details supplied) in relation to the prescription of Epilim to pregnant women will be reviewed; his views on the matter; and if he will make a statement on the matter. [18148/20]

Photo of Stephen DonnellyStephen Donnelly (Wicklow, Fianna Fail)
Link to this: Individually | In context | Oireachtas source

The issues and risks associated with the use of sodium valproate by women of childbearing age are well recognised by medicines regulators and healthcare professionals. Officials in the Department of Health, the HSE, and the Health Products Regulatory Authority are reviewing these issues at present, and considering the next steps that should be taken to minimise the risks involved in the use of this drug. This will include consideration of communications to patients, healthcare professionals, and other stakeholders.  

Comments

No comments

Log in or join to post a public comment.